← Return to the Medical Library
GLP-1 Safety · medical guide

GLP-1 side effects: what is common and when to seek help

Guide to Wegovy and Mounjaro digestive effects, hydration, and signs to seek medical attention.

GLP-1 side effectsnauseapancreatitissafety
Summary and conclusions

The essentials in less than a minute

  • Nausea, diarrhea, constipation, vomiting and abdominal pain are among the most common effects.
  • They tend to appear more during the start or increase of doses, but they should not normalize if they are intense or persistent.
  • Strong and sustained abdominal pain, dehydration, allergic reaction or visual changes require rapid evaluation.
  • Safety also depends on diabetes, other medications, history, and following the indicated escalation.

Common digestive effects

The EMA describes nausea, vomiting, diarrhea, constipation and abdominal pain among the common effects of Wegovy and Mounjaro. The intensity varies and many discomforts are concentrated around dose changes.

Annoyance, prudent self-care and limit
AnnoyanceGeneral measurementCheck if…
NauseaSmall portions, eat slowlyYou can’t hydrate or it gets worse
Vomiting/diarrheaLiquids in sipsYou urinate little, dizziness or it persists
ConstipationWater, movement, fiber toleratedSevere pain, bloating, or vomiting
Ebb/fullnessAvoid heavy meals and go to bed afterwardsChest pain or difficulty swallowing

Signs that require quick attention

Don’t wait if it appears

Severe and persistent abdominal pain that may radiate to the back; swelling of the face or throat, difficulty breathing; fainting; inability to retain fluids; or new visual changes, especially if you have diabetes.

Pancreatitis is rare but important. The leaflet also includes serious allergic reactions and specific precautions. The complete list depends on the product and should be consulted in its official information.

Hypoglycemia and interaction with other treatments

The risk of low glucose increases especially when these medications are used together with insulin or sulfonylureas. The doctor may need to adjust the treatment and order self-monitoring. Sweating, shaking, intense hunger, confusion, or weakness may be signs.

Do not reduce insulin or other medications on your own. Likewise, do not combine GLP-1 products or use two brands to accelerate results.

What to register for review

Date and dose administered
Symptom onset and duration
Foods and liquids tolerated
Other medications and glucose if applicable

A brief record allows you to distinguish a temporary discomfort from a pattern that requires de-escalation, a change of plan, or testing. The consultation must assess benefit and tolerance together.

P.

Medically reviewed by Dr Paulo

Medical reviewer for Costa Medical Services. Clinical coherence, safety and source quality reviewed.

✓ Ordem dos Médicos Portugal 69376 · Review August 30, 2026

Official and clinical sources

  1. EMA: Wegovy EPAR and adverse effects
  2. EMA: Mounjaro EPAR and adverse effects
  3. EMA: Wegovy, product information
  4. EMA: Mounjaro, product information

Regulatory information may change. Before publishing in WordPress, you should double-check the current version of the SmPC and leaflet.

Do you need a medical evaluation?

The consultation is used to review symptoms, history, medication and decide if online management is appropriate or if you need in-person care.

See medical consultation